Literature DB >> 6166306

Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.

W Hoffmann, W Werner, R Steiner, R Kaufmann.   

Abstract

Lymphocytes from 278 gynaecological patients (100 controls and 178 patients with a malignant condition) have been investigated for their response to encephalitogenic factor, cancer basic protein, and KCl extract of adenocarcinoma of the body of the uterus as "antigens", using tanned sheep erythrocytes ETS as indicator particles in the electrophoretic mobility test (EMT). Electrophoretic mobility was measured with a Zeiss cytopherometer. The study was split into three test series producing in the cancer group 66% correct positive test results (34% false negatives) and in the control group 83% correct negative results (17% false positives). Consequently, with the instrumentation used, EMT is, at least in our hands, not sufficiently reliable for the diagnosis of cancer.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166306      PMCID: PMC2010692          DOI: 10.1038/bjc.1981.88

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  Tumor-specific antigen solubilized by hypertonic potassium chloride.

Authors:  M S Meltzer; E J Leonard; H J Rapp; T Borsos
Journal:  J Natl Cancer Inst       Date:  1971-09       Impact factor: 13.506

2.  The macrophage electrophoretic migration test in cancer.

Authors:  A H Goldstone; L Kerr; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

3.  Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

4.  Isolation of an "antigen" from malignant tumours.

Authors:  P R Carnegie; E A Caspary; E J Field
Journal:  Br J Cancer Suppl       Date:  1973-08

5.  Sensitization of blood lymphocytes to possible antigens in neurological disease.

Authors:  E A Caspary; E J Field
Journal:  Eur Neurol       Date:  1970       Impact factor: 1.710

6.  Lymphocyte sensitisation: an in-vitro test for cancer?

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

7.  Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.

Authors:  E J Field; E A Caspary; K S Smith
Journal:  Br J Cancer Suppl       Date:  1973-08

8.  A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue.

Authors:  J P Dickinson; E A Caspary; E J Field
Journal:  Br J Cancer       Date:  1973-02       Impact factor: 7.640

9.  Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor.

Authors:  E J Field; E A Caspary
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640

10.  Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Br J Cancer       Date:  1973-01       Impact factor: 7.640

View more
  3 in total

Review 1.  Microfluidics for cell separation.

Authors:  Ali Asgar S Bhagat; Hansen Bow; Han Wei Hou; Swee Jin Tan; Jongyoon Han; Chwee Teck Lim
Journal:  Med Biol Eng Comput       Date:  2010-04-23       Impact factor: 2.602

2.  Cell electrophoresis for diagnostic purposes. II. Critical evaluation of conventional cytopherometry.

Authors:  W Hoffmann; R Kaufmann; R Steiner; W Werner
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

3.  Interaction of myelin basic protein with mononuclear cells: the primary reaction for the MEM and EMT tests.

Authors:  M Goppelt; M Grol; A Pingoud; K Schumacher
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.